Onderneming Protalix BioTherapeutics, Inc. TEL AVIV STOCK EXCHANGE
Aandelen
PLX
US74365A3095
Biotechnologie & Medisch Onderzoek
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
732,5 ILa | -.--% |
|
+3,29% | +69,68% |
26/06 | Transcript : Protalix BioTherapeutics, Inc. - Analyst/Investor Day | |
10/05 | Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024 |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Recombinant Therapeutic Proteins
100,0
%
| 48 | 100,0 % | 38 | 100,0 % | -19,50% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Global
56,3
%
| 22 | 46,9 % | 22 | 56,3 % | -3,33% |
United States
26,5
%
| 12 | 26,0 % | 10 | 26,5 % | -18,08% |
Brazil
16,7
%
| 9 | 19,8 % | 6 | 16,7 % | -32,29% |
Italy
0,5
%
| 3 | 7,2 % | 0 | 0,5 % | -94,50% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 57 | 30-06-19 |
Eyal Rubin
DFI | Director of Finance/CFO | 48 | 22-07-19 |
Yael Hayon
CTO | Chief Tech/Sci/R&D Officer | 41 | 05-07-20 |
Yaron Naos
COO | Chief Operating Officer | 60 | 01-01-04 |
Gina Balderas
PRN | Corporate Officer/Principal | - | - |
Fellous Yael
HRO | Human Resources Officer | - | 01-08-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pol Boudes
BRD | Director/Board Member | 67 | 01-12-19 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 01-12-19 |
Aharon Schwartz
BRD | Director/Board Member | 80 | 01-11-14 |
Amos Bar Shalev
BRD | Director/Board Member | 71 | 01-07-08 |
Eliot Forster
CHM | Chairman | 58 | 14-09-23 |
Shmuel Ben Zvi
BRD | Director/Board Member | 64 | 30-06-22 |
Dror Bashan
CEO | Chief Executive Officer | 57 | 30-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 316 084 | 62 627 738 ( 85,42 %) | 0 | 85,42 % |
Bedrijfsgegevens
Protalix Biotherapeutics, Inc.
2 University Plaza Suite 100
07601, Hackensack
+972 4 902 8100
http://www.protalix.com![Adres Protalix BioTherapeutics, Inc.(PLX)](https://cdn.zonebourse.com/static/address/56537225.png)
Sector
Verkoop per regio
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,59% | 45,51 mld. | |
-9,89% | 38,52 mld. | |
+38,08% | 38,13 mld. | |
+27,12% | 30,74 mld. | |
-8,64% | 26,03 mld. | |
+11,81% | 25,92 mld. | |
+45,08% | 14,13 mld. | |
+32,85% | 12,73 mld. | |
-7,19% | 11,29 mld. |